N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide
C35H25ClF6N10O4S — CID 154628927
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide
N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide (PubChem CID 154628927) has the molecular formula C35H25ClF6N10O4S and a molecular weight of 831.16 g/mol. Its IUPAC name is N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide.
Molecular Properties
| Compound Name | N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide |
|---|---|
| PubChem CID | 154628927 |
| Molecular Formula | C35H25ClF6N10O4S |
| Molecular Weight | 831.16 g/mol |
| Exact Mass | 830.14 |
| IUPAC Name | N-[1-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-6-cyano-4-oxopyrido[2,3-d]pyrimidin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide |
| SMILES | Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c(C(Cc4cc(F)cc(F)c4)NC(=O)Cn4nc(C(F)F)c5c4C(F)(F)[C@@H]4C[C@H]54)nc4ncc(C#N)cc4c3=O)c21 |
| InChI | InChI=1S/C35H25ClF6N10O4S/c1-50-28-23(4-3-21(36)26(28)32(48-50)49-57(2,55)56)52-33(46-31-19(34(52)54)7-15(11-43)12-44-31)22(8-14-5-16(37)9-17(38)6-14)45-24(53)13-51-29-25(27(47-51)30(39)40)18-10-20(18)35(29,41)42/h3-7,9,12,18,20,22,30H,8,10,13H2,1-2H3,(H,45,53)(H,48,49)/t18-,20+,22?/m0/s1 |
| InChIKey | UTFYYMPDYSDMTB-RUYIAYPLSA-N |
| XLogP | 5.29 |
| TPSA | 182.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 831.16 |
| LogP ≤ 5 | 5.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154628927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.